AGM Notes, page-92

In my opinion 2018 is the Vivagel story with the 2018 and 2019 price catalysts centered around it.
We may receive greater confidence in our DEP partnerships during 2018 however I do not expect great share price improvements from it.

In my opinion 2020 and beyond is the DEP story.

If the share price doubles or triples, its ETF time for me, being overweight speculative stocks has taken a great toll on my sanity and finances over the years.

Bring on the final submission of NDA by 28 Jan 2018 and I will be happy to wait another 6 months.